Old Web
English
Sign In
Acemap
>
authorDetail
>
Jan W. Traub
Jan W. Traub
Immunology
Glatiramer acetate
Multiple sclerosis
Biology
Natalizumab
4
Papers
34
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum Disorders.
2021
Pharmaceuticals, policy and law
Jan W. Traub
Leila Husseini
Martin S. Weber
Show All
Source
Cite
Save
Citations (2)
Differential Effects of MS Therapeutics on B Cells-Implications for Their Use and Failure in AQP4-Positive NMOSD Patients.
2020
International Journal of Molecular Sciences
Jan W. Traub
Silke Häusser-Kinzel
Martin S. Weber
Show All
Source
Cite
Save
Citations (6)
Glatiramer acetate immune modulates B-cell antigen presentation in treatment of MS
2020
Neuroimmunology and Neuroinflammation
Darius Häusler
Zivar Hajiyeva
Jan W. Traub
Scott S. Zamvil
Patrice H. Lalive
Wolfgang Brück
Martin S. Weber
Show All
Source
Cite
Save
Citations (9)
Natalizumab promotes activation and pro-inflammatory differentiation of peripheral B cells in multiple sclerosis patients
2019
Journal of Neuroinflammation
Jan W. Traub
Hannah L. Pellkofer
Katja Grondey
Ira Seeger
Christoph Rowold
Wolfgang Brück
Leila Husseini
Silke Häusser-Kinzel
Martin S. Weber
Show All
Source
Cite
Save
Citations (17)
1